Author

Mara B. Antonoff

The University of Texas MD Anderson Cancer CenterORCID 0000-0001-6247-9537Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1

Frequent Co-Authors

Alexandre ReubeniD· 2 shared Ara Asadur VaporciyaniD· 2 shared Boris SepesiiD· 2 shared Carmen BehrensiD· 2 shared Chi-Wan B. Chow· 2 shared Dan SuiD· 2 shared Harvey Ira PassiD· 2 shared Hoa Hoang Ngoc PhamiD· 2 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Alexandre ReubenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicineNature CommunicationsPeer-reviewedMay 11, 2021

Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features

Hitoshi Dejima, Xin Yang Hu, Runzhe Chen…·Jianjun J. Zhang

The paper investigates how anti-cancer immunity evolves from preneoplasia to invasive lung adenocarcinomas, identifying changes in immune response and molecular features that may facilitate immune evasion.

138 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky

Genetic & Genomic MedicineNature CommunicationsPeer-reviewedJan 29, 2021

Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas

Xin Hu, Marcos R. Estecio, Runzhe Chen…·Jianjun J. Zhang

This study examines DNA methylation changes and intra-tumor heterogeneity in lung adenocarcinoma progression, finding increased methylation aberrations and immunosuppression in later-stage lesions.

100 citationstop 3%

humanDNA methylation

𝕏 PostBluesky